Verastem Oncology competitors and similar companiesClear all

Verastem Oncology's competitors and similar companies include Tanvex Biopharma, Novartis, Relay Therapeutics, Mirati Therapeutics and InxMed.
Verastem Oncology
Verastem Oncology
Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer.
Tanvex Biopharma
Tanvex Biopharma
Tanvex Biopharma (formerly known as Ruenvex Biotech) is a company that manufactures and develops biosimilar and biologic products and drugs.
Novartis
Novartis
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
Relay Therapeutics
Relay Therapeutics
Relay Therapeutics was founded on the premise that putting protein motion at the heart of drug discovery can dramatically expand therapeutic possibilities.
Mirati Therapeutics
Mirati Therapeutics
Mirati Therapeutics is a clinical-stage oncology company developing therapeutics to address the genetic and immunological promoters of cancer.
InxMed
InxMed
InxMed (应世生物) is a clinical-stage biotechnology company that develops individualized medicines.
Founding Date
Founding Date
2010
Founding Date
2013
Founding Date
1996
Founding Date
2016
Founding Date
2013
Founding Date
2018
Type
Type
Public
Type
Public
Type
Public
Type
Private
Type
Public
Type
Private
Tags
Locations
Locations
Needham, US HQ
Walsrode, DE
Locations
New Taipei City, TW HQ
Irvine, US
San Diego, US
San Diego, US
Locations
Basel, CH HQ
Tirana, AL
Bir Mourad Raïs, DZ
Duc, AR
Macquarie Park, AU
Wien, AT
Baku, AZ
see more
Locations
Cambridge, US HQ
Locations
San Diego, US HQ
Locations
HQ
Employees
Employees
4864% decrease
Employees
1487% decrease
Employees
104,3231% decrease
Employees
3182% increase
Employees
418108% increase
Employees
157% increase
Valuation ($)
Valuation ($)
83.8 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
4.9 b
Valuation ($)
N/A
Twitter followers
Twitter followers
2.6 k
Twitter followers
N/A
Twitter followers
302.4 k
Twitter followers
N/A
Twitter followers
1.1 k
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
4
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
12
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
13
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
6.5
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
4.8
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
3.5
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
50%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
400342
Alexa Website Rank
309617
Alexa Website Rank
129099
Alexa Website Rank
461446
Alexa Website Rank
326059
Alexa Website Rank
743513
Employee Rating
Employee Rating
4.3
Employee Rating
3
Employee Rating
4.2
Employee Rating
5
Employee Rating
4.1
Employee Rating
N/A

Financial

Revenue (est.)
Revenue (est.)
$2.1m (FY, 2021)
Revenue (est.)
NT$5.4m (FY, 2021)
Revenue (est.)
$52.9b (FY, 2021)
Revenue (est.)
N/A
Revenue (est.)
$72.1m (FY, 2021)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
NT$1.9m (FY, 2021)
Cost of goods
$9.7b (FY, 2021)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
NT$96.4m (FY, 2021)
Gross profit
$45.1b (FY, 2021)
Gross profit
N/A
Gross profit
N/A
Gross profit
N/A
Net income
Net income
($71.2m) (FY, 2021)
Net income
(NT$1.5b) (FY, 2021)
Net income
$24b (FY, 2021)
Net income
N/A
Net income
($581.8m) (FY, 2021)
Net income
N/A

Operating

Phase I/II Trials Products
Phase I/II Trials Products
6 (FY, 2020)
Phase I/II Trials Products
N/A
Phase I/II Trials Products
107 (FY, 2021)
Phase I/II Trials Products
N/A
Phase I/II Trials Products
N/A
Phase I/II Trials Products
N/A

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 400m (almost 4 years ago)
Latest funding round
N/A
Latest funding round
$ 19m (about 2 years ago)
Total funding raised
Total funding raised
$ 170m
Total funding raised
$ 346.9m
Total funding raised
$ 6.5m
Total funding raised
$ 520m
Total funding raised
N/A
Total funding raised
$ 19m
For sources of this data, please see the company profile

View company profiles

Tanvex Biopharma
HQ
New Taipei City, TW
Employees
148↓ 7% decrease

Tanvex Biopharma (formerly known as Ruenvex Biotech) is a company that manufactures and develops biosimilar and biologic products and drugs.

View company
Novartis
HQ
Basel, CH
Employees
104,323↓ 1% decrease

Novartis is a company that researches, develops, manufactures, and markets healthcare products.

View company
Relay Therapeutics
HQ
Cambridge, US
Employees
318↑ 2% increase

Relay Therapeutics was founded on the premise that putting protein motion at the heart of drug discovery can dramatically expand therapeutic possibilities.

View company
Mirati Therapeutics
HQ
San Diego, US
Employees
418

Mirati Therapeutics is a clinical-stage oncology company developing therapeutics to address the genetic and immunological promoters of cancer.

View company